High levels of transforming growth factor-alpha (TGF-α) mRNA may predict local relapses in early stage urinary bladder cancer

European Journal of Cancer

Volumn 34, Issue 6, 1998, Pages 934-936

  Gazzaniga, P ^a   Gradilone, A ^a   Silvestri, I ^a   Gandini, O ^a   Napolitano, M ^a   Vercillo, R ^a   Vincenzoni, A ^b   Gallucci, M ^b   Frati, L ^a   Agliano', A M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Cristo Re Hospital   (Italy)

Author keywords

Bladder cancer; Prognosis; TGF

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER STAGING; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAPSE;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; PROGNOSIS; RNA, MESSENGER; RNA, NEOPLASM; TRANSFORMING GROWTH FACTOR ALPHA; URINARY BLADDER NEOPLASMS;

EID: 0032078221     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)10118-6     Document Type: Article

References (14)

1. Massague J. Transforming growth factor alpha. J Biol Chem 1990, 265(35), 21393-21396.
2. Anzano MA, Roberts AB, Smith JM, et al. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type α and type β transforming growth factors. Proc Natl Acad Sci USA 1983, 80, 6264-6268.
3. Issing WJ, Liebich G, Wustrow TP, Ullrich A. Coexpression of epidermal growth factor receptor and TGF-α and survival in upper aerodigestive tract cancer. Anticancer Res 1996, 16, 283-288.
4. Zhu L, Kim K, Domenico DR, et al. Adenocarcinoma of duodenum and ampulla of vater: clinicopathology study and expression of p53, c-neu, TGF-α, CEA and EMA. J Surg Oncol 1996, 61, 100-105.
5. Hise MK, Jacobs SC, Papadimitriou JC, et al. Transforming growth factor alpha expression in human renal cell carcinoma. Urology 1996,47, 29-33.
6. Nilsson O, Wangberg B, Kolby L, et al. Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumors. Int J Cancer 1995, 60, 645-651.
7. Pecur L, Kapitanovic S, Sonicki Z. et al. Prognostic significance of transforming growth factor alpha in human lung carcinoma: an immunohistochemical study. Anticancer Res 1994, 14, 2839-2843.
8. Albino AP, Davis BM, Nanus DM. Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res 1991, 51, 4815-4820.
9. Sidransky D, Von Eschenbach A, Tsai Y, et al. Identification of p53 gene mutations in bladder cancer and urine samples. Science 1991,252, 706-709.
10. Gazzaniga P, Gradilone A, Vercillo R, et al. bcl-2/bax mRNA expression ratio as prognostic factor in low grade urinary bladder cancer. Int J Cancer 1996, 69, 100-104.
11. Messing E. Growth factors in human bladder tumors. J Urol 1987, 131, 111A.
12. Neal DE, Marsh C, Bennet MK, et al. Epidermal growth factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet 1985, 1, 366-368.
13. Wright C, Mellon K, Johnston P, et al. Expression of p53, c-erb B2 and the epidermal growth factor in transitional cell carcinoma of the human urinary bladder. BrJ Cancer 1991, 41, 517-521.
14. Messing MM. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma. Cancer Res 1990, 50, 2530-2537.